Glucose and magnetic-responsive approach toward in situ nitric oxide bubbles controlled generation for hyperglycemia theranostics

Journal of Controlled Release

Volumn 228, Issue , 2016, Pages 87-95

  Yang, Fang ^a   Li, Mingxi ^a   Liu, Yang ^a   Wang, Tuantuan ^a   Feng, Zhenqiang ^a   Cui, Huating ^a   Gu, Ning ^a  

^a Southeast University   (China)

Author keywords

Alternating magnetic field; Blood glucose level; Diabetes; Glucose oxidase; Magnetic microvesicles; Nitric oxide bubbles

Indexed keywords

AMINO ACIDS; CONTROLLED DRUG DELIVERY; DRUG DOSAGE; GLUCOSE; GLUCOSE SENSORS; MAGNETIC FIELDS; MAGNETISM; MEDICAL PROBLEMS; NANOMAGNETICS; NANOPARTICLES; NITRIC OXIDE;

ALTERNATING MAGNETIC FIELD; BLOOD GLUCOSE LEVEL; DIABETIC NEPHROPATHY; GLUCOSE HOMEOSTASIS; MAGNETIC NANO-PARTICLES; MICROVESICLES; SEQUENTIAL MANNERS; STIMULI-RESPONSIVE;

GLUCOSE OXIDASE;

ARGININE; GLUCOSE; GLUCOSE OXIDASE; HYDROGEN PEROXIDE; NANOBUBBLE; NANOSHELL; NITRIC OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; DELAYED RELEASE FORMULATION; GLUCOSE BLOOD LEVEL; MAGNETITE NANOPARTICLE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG PENETRATION; ECHOGRAPHY; ENZYME ACTIVITY; ENZYME MECHANISM; EXPERIMENTAL DIABETIC NEPHROPATHY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NANOPHARMACEUTICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SINGLE DRUG DOSE; SPATIOTEMPORAL ANALYSIS; THERANOSTIC NANOMEDICINE; ANALYSIS; ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DIABETES MELLITUS, TYPE 2; DIAGNOSTIC IMAGING; MAGNETIC FIELD; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; ULTRASTRUCTURE;

ANIMALS; BLOOD GLUCOSE; DELAYED-ACTION PREPARATIONS; DIABETES MELLITUS, TYPE 2; DRUG DELIVERY SYSTEMS; GLUCOSE OXIDASE; HYDROGEN PEROXIDE; HYPERGLYCEMIA; MAGNETIC FIELDS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MICE; NITRIC OXIDE; THERANOSTIC NANOMEDICINE;

EID: 84960350841     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2016.03.002     Document Type: Article

References (51)

1. T. Dreifuss, O. Betzer, M. Shilo, A. Popovtzer, M. Motiei, and R. Popovtzer A challenge for theranostics: is the optimal particle for therapy also optimal for diagnostics? Nanoscale 7 2015 15175 15184
2. S.K. Patel, and J.M. Janjic Macrophage targeted theranostics as personalized nanomedicine strategies for inflammatory diseases Theranostics 5 2015 150 172
3. K. Park Controlled drug delivery systems: past forward and future back J. Control. Release 190 2014 3 8
4. B. Jeong, S.W. Kim, and Y.H. Bae Thermosensitive sol-gel reversible hydrogels Adv. Drug Deliv. Rev. 54 2002 37 51
5. E. Bringas, O. Koysuren, D.V. Quach, M. Mahmoudi, E. Aznar, J.D. Roehling, M.D. Marcos, R. Martinez-Manez, and P. Stroeve Triggered release in lipid bilayer-capped mesoporous silica nanoparticles containing SPION using an alternating magnetic field Chem. Commun. 48 2012 5647 5649
6. J. Di, J. Price, X. Gu, X. Jiang, Y. Jing, and Z. Gu Ultrasound-triggered regulation of blood glucose levels using injectable nano-network Adv. Healthc. Mater. 3 2014 811 816
7. S. Shah, P.K. Sasmal, and K.B. Lee Photo-triggerable hydrogel-nanoparticle hybrid scaffolds for remotely controlled drug delivery J. Mater. Chem. B Mater. Biol. Med. 2 2014 7685 7693
8. Y. Li, R.S. Shawgo, B. Tyler, P.T. Henderson, J.S. Vogel, A. Rosenberg, P.B. Storm, R. Langer, H. Brem, and M.J. Cima In vivo release from a drug delivery MEMS device J. Control. Release 100 2004 211 219
9. J. Liu, Y. Huang, A. Kumar, A. Tan, S. Jin, A. Mozhi, and X.J. Liang pH-sensitive nano-systems for drug delivery in cancer therapy Biotechnol. Adv. 32 2014 693 710
10. Y. Elani, R.V. Law, and O. Ces Vesicle-based artificial cells as chemical microreactors with spatially segregated reaction pathways Nat. Commun. 5 2014 5305
11. A. Wang, M. Guo, N. Wang, J. Zhao, W. Qi, F. Muhammad, L. Chen, Y. Guo, N.T. Nguyen, and G. Zhu Redox-mediated dissolution of paramagnetic nanolids to achieve a smart theranostic system Nanoscale 6 2014 5270 5278
12. G. Qing, M. Li, L. Deng, Z. Lv, P. Ding, and T. Sun Smart drug release systems based on stimuli-responsive polymers Mini Rev. Med. Chem. 13 2013 1369 1380
13. Y. Li, T.Y. Lin, Y. Luo, Q. Liu, W. Xiao, W. Guo, D. Lac, H. Zhang, C. Feng, S. Wachsmann-Hogiu, J.H. Walton, S.R. Cherry, D.J. Rowland, D. Kukis, C. Pan, and K.S. Lam A smart and versatile theranostic nanomedicine platform based on nanoporphyrin Nat. Commun. 5 2014 4712
14. S.H. Hu, S.Y. Chen, and X. Gao Multifunctional nanocapsules for simultaneous encapsulation of hydrophilic and hydrophobic compounds and on-demand release ACS Nano 6 2012 2558 2565
15. V.I. Shubayev, T.N. Pisanic, and S. Jin Magnetic nanoparticles for theragnostics Adv. Drug Deliv. Rev. 61 2009 467 477
16. 3@Au magnetic gold nanoflowers for efficient cancer theranostics Adv. Mater. 27 34 2015 5049 5056
17. W. Cai, and X. Chen Nanoplatforms for targeted molecular imaging in living subjects Small 3 2007 1840 1854
18. M.K. Yu, J. Park, and S. Jon Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy Theranostics 2 2012 3 44
19. A. Curcio, R. Marotta, A. Riedinger, D. Palumberi, A. Falqui, and T. Pellegrino Magnetic pH-responsive nanogels as multifunctional delivery tools for small interfering RNA (siRNA) molecules and iron oxide nanoparticles (IONPs) Chem. Commun. 48 2012 2400 2402
20. J. Estelrich, E. Escribano, J. Queralt, and M.A. Busquets Iron oxide nanoparticles for magnetically-guided and magnetically-responsive drug delivery Int. J. Mol. Sci. 16 2015 8070 8101
21. R.R. Holman, S.K. Paul, M.A. Bethel, D.R. Matthews, and H.A. Neil 10-year follow-up of intensive glucose control in type 2 diabetes N. Engl. J. Med. 359 2008 1577 1589
22. D.M. Nathan Diabetes: advances in diagnosis and treatment JAMA 314 2015 1052 1062
23. X. Chen, W. Wu, Z. Guo, J. Xin, and J. Li Controlled insulin release from glucose-sensitive self-assembled multilayer films based on 21-arm star polymer Biomaterials 32 2011 1759 1766
24. Z. Gu, T.T. Dang, M. Ma, B.C. Tang, H. Cheng, S. Jiang, Y. Dong, Y. Zhang, and D.G. Anderson Glucose-responsive microgels integrated with enzyme nanocapsules for closed-loop insulin delivery ACS Nano 7 2013 6758 6766
25. W. Zhao, H. Zhang, Q. He, Y. Li, J. Gu, L. Li, H. Li, and J. Shi A glucose-responsive controlled release of insulin system based on enzyme multilayers-coated mesoporous silica particles Chem. Commun. 47 2011 9459 9461
26. J.O. Lundberg, M.T. Gladwin, and E. Weitzberg Strategies to increase nitric oxide signalling in cardiovascular disease Nat. Rev. Drug Discov. 14 2015 623 641
27. M. Valko, D. Leibfritz, J. Moncol, M.T. Cronin, M. Mazur, and J. Telser Free radicals and antioxidants in normal physiological functions and human disease Int. J. Biochem. Cell Biol. 39 2007 44 84
28. J. Passauer, F. Pistrosch, and E. Bussemaker Nitric oxide in chronic renal failure Kidney Int. 67 2005 1665 1667
29. G.A. Spinas, R. Laffranchi, I. Francoys, I. David, C. Richter, and M. Reinecke The early phase of glucose-stimulated insulin secretion requires nitric oxide Diabetologia 41 1998 292 299
30. F. Paneni, S. Costantino, and F. Cosentino Role of oxidative stress in endothelial insulin resistance World J. Diabetes 6 2015 326 332
31. P. Vallance Nitric oxide: therapeutic opportunities Fundam. Clin. Pharmacol. 17 2003 1 10
32. J. Kim, G. Saravanakumar, H.W. Choi, D. Park, and W.J. Kim A platform for nitric oxide delivery J. Mater. Chem. B Mater. Biol. Med. 2 2014 341 356
33. F. Yang, P. Chen, W. He, N. Gu, X. Zhang, K. Fang, Y. Zhang, J. Sun, and J. Tong Bubble microreactors triggered by an alternating magnetic field as diagnostic and therapeutic delivery devices Small 6 2010 1300 1305
34. 4 nanomicelles for in vivo MR imaging J. Nanosci. Nanotechno. 15 2015 4111 4118
35. L. Duan, F. Yang, L. Song, K. Fang, J. Tian, Y. Liang, M. Li, N. Xu, Z. Chen, Y. Zhang, and N. Gu Controlled assembly of magnetic nanoparticles on microbubbles for multimodal imaging Soft Matter 11 2015 5492 5500
36. K. Fang, L. Song, Z. Gu, F. Yang, Y. Zhang, and N. Gu Magnetic field activated drug release system based on magnetic PLGA microspheres for chemo-thermal therapy Colloids Surf. B Biointerfaces 136 2015 712 720
37. W.W. Cheng, Z.Q. Lin, Q. Ceng, B.F. Wei, X.J. Fan, H.S. Zhang, W. Zhang, H.L. Yang, H.L. Liu, J. Yan, L. Tian, B.C. Lin, S.M. Ding, and Z.G. Xi Single-wall carbon nanotubes induce oxidative stress in rat aortic endothelial cells Toxicol. Mech. Methods 22 2012 268 276
38. R.A. Siegel Stimuli sensitive polymers and self regulated drug delivery systems: a very partial review J. Control. Release 190 2014 337 351
39. T. Pompe, S. Zschoche, N. Herold, K. Salchert, M.F. Gouzy, C. Sperling, and C. Werner Maleic anhydride copolymers-a versatile platform for molecular biosurface engineering Biomacromolecules 4 2003 1072 1079
40. D.J. Pochan, J. Zhu, K. Zhang, K.L. Wooley, C. Miesch, and T. Emrick Multicompartment and multigeometry nanoparticle assembly Soft Matter 7 2011 2500
41. A. Rosler, G.W. Vandermeulen, and H.A. Klok Advanced drug delivery devices via self-assembly of amphiphilic block copolymers Adv. Drug Deliv. Rev. 53 2001 95 108
42. K. Fang, L. Song, Z. Gu, F. Yang, Y. Zhang, and N. Gu Magnetic field activated drug release system based on magnetic PLGA microspheres for chemo-thermal therapy Colloids Surf. B Biointerfaces 136 2015 712 720
43. P. Tessari Nitric oxide in the normal kidney and in patients with diabetic nephropathy J. Nephrol. 28 2015 257 268
44. J. Leiper, and M. Nandi The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis Nat. Rev. Drug Discov. 10 2011 277 291
45. S.R. Vincent Nitric oxide and arginine-evoked insulin secretion Science 258 1992 1376 1378
46. L.P. Li, J. Lu, T. Franklin, Y. Zhou, R. Solomon, and P.V. Prasad Effect of iodinated contrast medium in diabetic rat kidneys as evaluated by blood-oxygenation-level-dependent magnetic resonance imaging and urinary neutrophil gelatinase-associated lipocalin Investig. Radiol. 50 2015 392 396
47. X.G. Peng, Y.Y. Bai, F. Fang, X.Y. Wang, H. Mao, G.J. Teng, and S. Ju Renal lipids and oxygenation in diabetic mice: noninvasive quantification with MR imaging Radiology 269 2013 748 757
48. T. Nakagawa, K. Tanabe, B.P. Croker, R.J. Johnson, M.B. Grant, T. Kosugi, and Q. Li Endothelial dysfunction as a potential contributor in diabetic nephropathy Nat. Rev. Nephrol. 7 2011 36 44
49. A.B. Seabra, G.Z. Justo, and P.S. Haddad State of the art, challenges and perspectives in the design of nitric oxide-releasing polymeric nanomaterials for biomedical applications Biotechnol. Adv. 33 2015 1370 1379
50. Q. Wang, H. Li, Y. Xiao, S. Li, B. Li, X. Zhao, L. Ye, B. Guo, X. Chen, Y. Ding, and C. Bao Locally controlled delivery of TNF alpha antibody from a novel glucose-sensitive scaffold enhances alveolar bone healing in diabetic conditions J. Control. Release 206 2015 232 242
51. Y.S. Jo, A.J. van der Vlies, J. Gantz, T.N. Thacher, S. Antonijevic, S. Cavadini, D. Demurtas, N. Stergiopulos, and J.A. Hubbell Micelles for delivery of nitric oxide J. Am. Chem. Soc. 131 2009 14413 14418